These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26556626)

  • 61. The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer.
    Xu C; Li W; Qiu P; Xia Y; Du X; Wang F; Shen L; Chen Q; Zhao Y; Jin R; Wu J; Liang G; Li X
    Anticancer Drugs; 2015 Apr; 26(4):379-87. PubMed ID: 25521558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.
    Fan L; Li W; Ying S; Shi L; Wang Z; Chen G; Ye H; Wu X; Wu J; Liang G; Li X
    Tumour Biol; 2015 Sep; 36(9):7233-41. PubMed ID: 25894376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.
    Yu Y; Gao S; Li Q; Wang C; Lai X; Chen X; Wang R; Di J; Li T; Wang W; Wu X
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1321-8. PubMed ID: 22481251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells.
    Liekens S; Gijsbers S; Vanstreels E; Daelemans D; De Clercq E; Hatse S
    Mol Pharmacol; 2007 Mar; 71(3):695-703. PubMed ID: 17158200
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel FGF2 antagonist peptide P8 with potent antiproliferation activity.
    Fan L; Xie H; Chen L; Ye H; Ying S; Wang C; Wu X; Li W; Wu J; Liang G; Li X
    Tumour Biol; 2014 Oct; 35(10):10571-9. PubMed ID: 25062723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peptidomimetic suppresses proliferation and invasion of gastric cancer cells by fibroblast growth factor 2 signaling cascade blockage.
    Li W; Du X; Chen Q; Kang Y; Xu C; Fan L; Ye H; Ying S; Shi L; Jin R; Wu J; Liang G; Li X
    Anticancer Drugs; 2016 Mar; 27(3):164-72. PubMed ID: 26556626
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FGF signaling network in the gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
    Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
    Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.